Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry
Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMJ PUBLISHING GROUP
Autores
VITALE, Antonio
CAGGIANO, Valeria
LOPALCO, Giuseppe
CICCIA, Francesco
ALMAGHLOUTH, Ibrahim A.
RUSCITTI, Piero
SFIKAKIS, Petros P.
TUFAN, Abdurrahman
DAGNA, Lorenzo
Citação
RMD OPEN, v.9, n.4, article ID e003578, 12p, 2023
Resumo
Objective Still's disease is more frequently observed in the paediatric context, but a delayed onset is not exceptional both in the adulthood and in the elderly. However, whether paediatric-onset, adult-onset and elderly-onset Still's disease represent expressions of the same disease continuum or different clinical entities is still a matter of controversy. The aim of this study is to search for any differences in demographic, clinical features and response to treatment between pediatric-onset, adult-onset and elderly-onset Still's disease. Methods Subjects included in this study were drawn from the International AutoInflammatory Disease Alliance Network registry for patients with Still's disease. Results A total of 411 patients suffering from Still's disease were enrolled; the disease occurred in the childhood in 65 (15.8%) patients, in the adult 314 (76.4%) patients and in the elderly in 32 (7.8%) patients. No statistically significant differences at post-hoc analysis were observed in demographic features of the disease between pediatric-onset, adult-onset and elderly-onset Still's disease. The salmon-coloured skin rash (p=0.004), arthritis (p=0.009) and abdominal pain (p=0.007) resulted significantly more frequent among paediatric patients than in adult cases, while pleuritis (p=0.015) and arthralgia (p<0.0001) were significantly more frequent among elderly-onset patients compared with paediatric-onset subjects. Regarding laboratory data, thrombocytosis was significantly more frequent among paediatric patients onset compared with adult-onset subjects (p<0.0001), while thrombocytopenia was more frequent among elderly-onset patients although statistical significance was only bordered. No substantial differences were observed in the response to treatments. Conclusions Despite some minor difference between groups, overall, demographic, clinical, laboratory and treatments aspects of Still's disease were similarly observed in patients at all ages. This supports that pediatric-onset, adult-onset and elderly-onset Still's disease is the same clinical condition arising in different ages.
Palavras-chave
Still's Disease, Adult-Onset, Epidemiology, Child
Referências
- Aicha B, 2023, CURR RHEUMATOL REV, V19, P235, DOI 10.2174/1573397118666220617101447
- Berardicurti O., 2021, Rheumatology, V60, P4844, DOI [10.1093/rheumatology/keaa904, DOI 10.1093/RHEUMATOLOGY/KEAA904]
- CUSH JJ, 1987, ARTHRITIS RHEUM, V30, P186, DOI 10.1002/art.1780300209
- Di Cola I, 2022, CLIN EXP RHEUMATOL, V40, P1517, DOI 10.55563/clinexprheumatol/0215kv
- Di Cola I, 2023, JOINT BONE SPINE, V90, DOI 10.1016/j.jbspin.2023.105576
- Dunger-Baldauf C, 2022, RHEUMATOL THER, V9, P753, DOI 10.1007/s40744-021-00422-9
- Efthimiou P, 2021, SEMIN ARTHRITIS RHEU, V51, P858, DOI 10.1016/j.semarthrit.2021.06.004
- Fardet L, 2014, ARTHRITIS RHEUMATOL, V66, P2613, DOI 10.1002/art.38690
- Fautrel B, 2002, MEDICINE, V81, P194, DOI 10.1097/00005792-200205000-00003
- Feist E, 2018, CLIN EXP RHEUMATOL, V36, P668
- Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039
- Inoue N, 2016, CLIN IMMUNOL, V169, P8, DOI 10.1016/j.clim.2016.05.010
- Jamilloux Y, 2015, IMMUNOL RES, V61, P53, DOI 10.1007/s12026-014-8561-9
- Kishida D, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10932-3
- Kudela H, 2019, BMC RHEUMATOL, V3, DOI 10.1186/s41927-019-0053-z
- Lenert A, 2020, RHEUMATOLOGY, V59, P1788, DOI 10.1093/rheumatology/keaa154
- Li S, 2023, J TRANSL AUTOIMMUN, V6, DOI 10.1016/j.jtauto.2023.100196
- Martini A, 2019, J RHEUMATOL, V46, P190, DOI 10.3899/jrheum.180168
- Maruyama A, 2021, MOD RHEUMATOL, V31, P862, DOI 10.1080/14397595.2020.1829340
- Mollaeian A, 2021, BMC RHEUMATOL, V5, DOI 10.1186/s41927-021-00201-7
- Neau PA, 2022, J CLIN MED, V11, DOI 10.3390/jcm11226703
- Nirmala N, 2015, PEDIATR RHEUMATOL, V13, DOI 10.1186/s12969-015-0047-3
- Petty RE, 2004, J RHEUMATOL, V31, P390
- Ravelli A, 2016, ARTHRITIS RHEUMATOL, V68, P566, DOI 10.1002/art.39332
- Ruscitti P, 2022, CLIN RHEUMATOL, V41, P3597, DOI 10.1007/s10067-022-06357-y
- Ruscitti P, 2022, RHEUMATOLOGY, V61, P4124, DOI 10.1093/rheumatology/keac027
- Sugiyama T, 2022, ARTHRITIS RES THER, V24, DOI 10.1186/s13075-021-02708-3
- Suzuki E, 2021, TOHOKU J EXP MED, V255, P195, DOI 10.1620/tjem.255.195
- Vitale A., 2022, Front Med, V9, DOI [10.3389/fmed.2022.908501, DOI 10.3389/FMED.2022.908501]
- Yagishita M, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-25514-6
- YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424